Host-directed Drug Therapy for Tuberculosis

Overview

Journal Nat Chem Biol

Specialties Biochemistry
Biology
Chemistry

Date 2015 Sep 18

PMID 26379013

Citations 22

Authors

Reto Guler

Frank Brombacher

Affiliations

Soon will be listed here.

Citing Articles

Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis.

Raqib R, Sarker P Biomolecules. 2025; 14(12.

PMID: 39766204 PMC: 11673177. DOI: 10.3390/biom14121497.

Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning.

Glajzner P, Bernat A, Jasinska-Stroschein M Front Pharmacol. 2024; 15:1397602.

PMID: 38910882 PMC: 11193365. DOI: 10.3389/fphar.2024.1397602.

Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.

Zhao L, Fan K, Sun X, Li W, Qin F, Shi L Front Immunol. 2024; 14:1305325.

PMID: 38259491 PMC: 10800548. DOI: 10.3389/fimmu.2023.1305325.

Antisense Therapy for Infectious Diseases.

Buthelezi L, Pillay S, Ntuli N, Gcanga L, Guler R Cells. 2023; 12(16).

PMID: 37626929 PMC: 10453568. DOI: 10.3390/cells12162119.

Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to infection in mice.

Jones S, Ozturk M, Kieswetter N, Poswayo S, Hazra R, Tamgue O Front Immunol. 2022; 13:948047.

PMID: 36119114 PMC: 9481033. DOI: 10.3389/fimmu.2022.948047.

References

Sharma G, Upadhyay S, Srilalitha M, Nandicoori V, Khosla S . The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding. Nucleic Acids Res. 2015; 43(8):3922-37. PMC: 4417171. DOI: 10.1093/nar/gkv261. View

Kim K, An D, Song J, Yoon J, Kim H, Yoon H . Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A. 2012; 109(20):7729-34. PMC: 3356628. DOI: 10.1073/pnas.1120251109. View

Maloney E, Stankowska D, Zhang J, Fol M, Cheng Q, Lun S . The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides. PLoS Pathog. 2009; 5(7):e1000534. PMC: 2713425. DOI: 10.1371/journal.ppat.1000534. View

Singhal A, Jie L, Kumar P, Hong G, Leow M, Paleja B . Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014; 6(263):263ra159. DOI: 10.1126/scitranslmed.3009885. View

Forrest A, Kawaji H, Rehli M, Baillie J, de Hoon M, Haberle V . A promoter-level mammalian expression atlas. Nature. 2014; 507(7493):462-70. PMC: 4529748. DOI: 10.1038/nature13182. View

Parihar S, Guler R, Khutlang R, Lang D, Hurdayal R, Mhlanga M . Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. J Infect Dis. 2013; 209(5):754-63. DOI: 10.1093/infdis/jit550. View

Iannaccone M, Dorhoi A, Kaufmann S . Host-directed therapy of tuberculosis: what is in it for microRNA?. Expert Opin Ther Targets. 2014; 18(5):491-4. DOI: 10.1517/14728222.2014.897696. View

Parihar S, Guler R, Lang D, Suzuki H, Marais A, Brombacher F . Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape. PLoS One. 2013; 8(9):e75490. PMC: 3782446. DOI: 10.1371/journal.pone.0075490. View

Houben D, Demangel C, van Ingen J, Perez J, Baldeon L, Abdallah A . ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol. 2012; 14(8):1287-98. DOI: 10.1111/j.1462-5822.2012.01799.x. View

10.

Arner E, Daub C, Vitting-Seerup K, Andersson R, Lilje B, Drablos F . Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015; 347(6225):1010-4. PMC: 4681433. DOI: 10.1126/science.1259418. View

11.

Barichievy S, Naidoo J, Mhlanga M . Non-coding RNAs and HIV: viral manipulation of host dark matter to shape the cellular environment. Front Genet. 2015; 6:108. PMC: 4374539. DOI: 10.3389/fgene.2015.00108. View

12.

Li J, Chai Q, Zhang Y, Li B, Wang J, Qiu X . Mycobacterium tuberculosis Mce3E suppresses host innate immune responses by targeting ERK1/2 signaling. J Immunol. 2015; 194(8):3756-67. DOI: 10.4049/jimmunol.1402679. View

13.

Hawn T, Shah J, Kalman D . New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev. 2015; 264(1):344-62. PMC: 4571192. DOI: 10.1111/imr.12255. View

14.

Yi Z, Fu Y, Ji R, Li R, Guan Z . Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One. 2012; 7(8):e43184. PMC: 3416796. DOI: 10.1371/journal.pone.0043184. View

15.

Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F . Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 2008; 4(11):e1000204. PMC: 2575403. DOI: 10.1371/journal.ppat.1000204. View

16.

Gatfield J, Pieters J . Essential role for cholesterol in entry of mycobacteria into macrophages. Science. 2000; 288(5471):1647-50. DOI: 10.1126/science.288.5471.1647. View

17.

Ng V, Cox J, Sousa A, MacMicking J, McKinney J . Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol. 2004; 52(5):1291-302. DOI: 10.1111/j.1365-2958.2004.04078.x. View

18.

Wallis R, Hafner R . Advancing host-directed therapy for tuberculosis. Nat Rev Immunol. 2015; 15(4):255-63. DOI: 10.1038/nri3813. View

19.

Pennini M, Pai R, Schultz D, Boom W, Harding C . Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol. 2006; 176(7):4323-30. DOI: 10.4049/jimmunol.176.7.4323. View

20.

Liappis A, Kan V, Rochester C, Simon G . The effect of statins on mortality in patients with bacteremia. Clin Infect Dis. 2001; 33(8):1352-7. DOI: 10.1086/323334. View